Buzzi Unicem : Report on the purchase of treasury shares
November 09, 2018 at 02:14 pm EST
Share
November 09, 2018
Buzzi Unicem SpA announces that during the period from November 5, 2018 through November 9, 2018 it acquired no. 650,186 treasury shares for a total consideration of 10,946,727.20 Euro, as authorized by the Ordinary General Meeting on May 10, 2018.
Details of the daily transactions on the Mercato Telematico Azionario are as follows:
Date
Number of ordinary
shares purchased
Average price
(Euro)
Consideration
(Euro)
11/05/2018
100,000
16.9896
1,698,960.00
11/06/2018
241,000
16.6889
4,022,024.90
11/07/2018
212,000
16.8745
3,577,394.00
11/08/2018
45,119
16.9936
766,734.24
11/09/2018
52,067
16.9323
881,614.06
Total
650,186
16.8363
10,946,727.20
Attached to this press release is a daily recap of the purchase transactions carried out during the reference period.
Following the above purchases, the Company holds no. 4,839,186 ordinary shares and no. 29,290 saving shares as of November 9, 2018, equal to 2.36% of the issued share capital.
Buzzi Unicem S.p.A. published this content on 09 November 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 09 November 2018 19:13:10 UTC
Buzzi SpA, formerly known as Buzzi Unicem SpA, is an Italy-based company engaged in the manufacture of construction materials. The Company is primarily active in the production, distribution, and sale of cement, ready-mix concrete, and natural aggregates. The Companyâs operations are located in Italy, the United States, Germany, Luxembourg and the Netherlands, Poland, the Czech Republic and Slovakia, Ukraine, Russia, Mexico, Brazil, and Algeria. The three main geographical area with the higher generation of revenues are: the United States, Germany, and Mexico. The Firm is also engaged in the activity of Research and Development with the aim of developing and experimenting innovations to be used in the production chain and for their products. This activity is performed in cooperation with national research centers, universities, and private laboratories.